Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: Cardiology's average salary rises | New hydroxychloroquine research | Heart transplants & COVID-19

News You Need to Know Today
Week in Review: Cardiology's average salary rises | New hydroxychloroquine research | Heart transplants & COVID-19
Saturday, May 16, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Top Stories

Cardiologists’ average salary rises to $438K, No. 4 among all specialties

This continues a steady rise in pay for the specialty—the same report recorded cardiology’s average salary as $430,000 in 2019, $423,000 in 2018 and $410,000 in 2017.

READ MORE >
Money
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists’ average salary rises to $438K, No. 4 among all specialties

Share on Twitter Share on Facebook Share on Linkedin
Money
This continues a steady rise in pay for the specialty—the same report recorded cardiology’s average salary as $430,000 in 2019, $423,000 in 2018 and $410,000 in 2017.
READ MORE >

Beloved Miami cardiologist dies from coronavirus complications

A 50-year-old cardiologist has died from complications related to COVID-19.

READ MORE >
Florida
Share on Twitter Share on Facebook Share on Linkedin

Beloved Miami cardiologist dies from coronavirus complications

Share on Twitter Share on Facebook Share on Linkedin
Florida
A 50-year-old cardiologist has died from complications related to COVID-19.
READ MORE >

Latest study suggests hydroxychloroquine makes minimal impact as COVID-19 treatment

The potential use of hydroxychloroquine to treat COVID-19 has been one of the biggest stories of the current pandemic.

READ MORE >
medicine-4097308_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

Latest study suggests hydroxychloroquine makes minimal impact as COVID-19 treatment

Share on Twitter Share on Facebook Share on Linkedin
medicine-4097308_960_720.jpg
The potential use of hydroxychloroquine to treat COVID-19 has been one of the biggest stories of the current pandemic.
READ MORE >

COVID-19 especially harmful for heart transplant recipients

Heart transplant (HT) recipients have an increased risk of experiencing severe complications if infected with COVID-19, according to new findings published in JAMA Cardiology.

READ MORE >
transplant.jpg
Share on Twitter Share on Facebook Share on Linkedin

COVID-19 especially harmful for heart transplant recipients

Share on Twitter Share on Facebook Share on Linkedin
transplant.jpg
Heart transplant (HT) recipients have an increased risk of experiencing severe complications if infected with COVID-19, according to new findings published in JAMA Cardiology.
READ MORE >

When patients can safely resume exercising after a COVID-19 diagnosis

As COVID-19 patients begin to bounce back, they are sure to have plenty of important questions about the recovery process. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

When patients can safely resume exercising after a COVID-19 diagnosis

Share on Twitter Share on Facebook Share on Linkedin
As COVID-19 patients begin to bounce back, they are sure to have plenty of important questions about the recovery process. 
READ MORE >

Featured Articles

FDA clears Philips imaging solutions for management of cardiac, lung complications related to COVID-19

Royal Philips announced Wednesday, May 13, that its ultrasound imaging solutions have been cleared by the FDA for the management of cardiac and lung complications associated with COVID-19.

READ MORE >
Covid Hospital
Share on Twitter Share on Facebook Share on Linkedin

FDA clears Philips imaging solutions for management of cardiac, lung complications related to COVID-19

Share on Twitter Share on Facebook Share on Linkedin
Covid Hospital
Royal Philips announced Wednesday, May 13, that its ultrasound imaging solutions have been cleared by the FDA for the management of cardiac and lung complications associated with COVID-19.
READ MORE >

ACC updates data registries to track COVID-19’s impact on heart disease patients

The American College of Cardiology announced Monday, May 11, that it will start using two data registries to track and study the relationship between COVID-19 and heart disease.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

ACC updates data registries to track COVID-19’s impact on heart disease patients

Share on Twitter Share on Facebook Share on Linkedin
The American College of Cardiology announced Monday, May 11, that it will start using two data registries to track and study the relationship between COVID-19 and heart disease.
READ MORE >

Mavacamten shows potential for treating hypertrophic cardiomyopathy in EXPLORER-HCM trial

Mavacamten has demonstrated value as a treatment option for patients with obstructive hypertrophic cardiomyopathy (HCM), according to results from the EXPLORER-HCM phase III clinical trial.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Mavacamten shows potential for treating hypertrophic cardiomyopathy in EXPLORER-HCM trial

Share on Twitter Share on Facebook Share on Linkedin
Mavacamten has demonstrated value as a treatment option for patients with obstructive hypertrophic cardiomyopathy (HCM), according to results from the EXPLORER-HCM phase III clinical trial.
READ MORE >

A call to action: 5 ways to prevent venous thromboembolism in hospitalized patients

Venous thromboembolism is a common complication among hospitalized patients, one that leads to longer lengths of stay and costs health systems up to $10 billion annually.

READ MORE >
Hospital Bed
Share on Twitter Share on Facebook Share on Linkedin

A call to action: 5 ways to prevent venous thromboembolism in hospitalized patients

Share on Twitter Share on Facebook Share on Linkedin
Hospital Bed
Venous thromboembolism is a common complication among hospitalized patients, one that leads to longer lengths of stay and costs health systems up to $10 billion annually.
READ MORE >

Eko’s AI model for low ejection fraction receives FDA EUA to boost pandemic care

The algorithm, developed as part of a collaboration with Mayo Clinic, received Breakthrough Device designation back in December 2019.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Eko’s AI model for low ejection fraction receives FDA EUA to boost pandemic care

Share on Twitter Share on Facebook Share on Linkedin
The algorithm, developed as part of a collaboration with Mayo Clinic, received Breakthrough Device designation back in December 2019.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR Highlights: Predicting long-term outcomes | SCAI, ACC & STS share a message | Weight loss drug linked to key benefits
TAVR or SAVR? A closer look at those decisions | New Impella 5.5 data | First patient enrolled in massive heart failure trial
Teen's death at center of new lawsuit | Surgery outperforms GLP-1 drugs | Long-term antidepressant use & SCD
AI helps 3D imaging labs evolve | Catheters recalled over safety risk | New ways to predict TAVR outcomes
Looking Back: Cardiologist fired for speaking out | Hospital sues practice | Strokes after PFA | Energy drinks & heart disease
Surgery outperforms GLP-1 drugs | CEPDs fail to make an impact | Redo TAVR: Supra-annular vs. intra-annular valves
Week in Review: FDA clears imaging platform | Vascular device linked to deaths | GLP-1 drugs & AFib | Pacemakers recalled again

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …3
    • Page 4
    • Page 5
    • Page 6
    • Current page 7
    • Page 8
    • Page 9
    • Page 10
    • Page 11 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme